Stefan Salomon
Global Director, Rare Blood Disorders Early Assets @ Novo
About Stefan Salomon
Stefan Salomon serves as the Global Director of Rare Blood Disorders Early Assets at Novo Nordisk, a position he has held since 2021 in Zurich, Switzerland. He completed his MPharm at the University of Vienna and earned his PhD from The School of Pharmacy, University of London, where he also worked as a PhD student from 2004 to 2008.